These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 6687414

  • 1. The accumulation of [35S]methimazole by human and rat lymphocytes.
    Shewring GS, Lazarus JH.
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):68-70. PubMed ID: 6687414
    [Abstract] [Full Text] [Related]

  • 2. The accumulation of [35S]methimazole by monocytes and macrophages.
    Weetman AP, Gunn C, Hall R, McGregor AM.
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):366-70. PubMed ID: 6209906
    [Abstract] [Full Text] [Related]

  • 3. Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole.
    Okabe N, Inoue K, Mori R.
    J Clin Lab Immunol; 1983 Aug; 11(4):167-71. PubMed ID: 6689431
    [Abstract] [Full Text] [Related]

  • 4. Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism.
    Nakashima T, Taurog A.
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):637-48. PubMed ID: 476986
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A, Taurog A, Engler H, Dorris ML.
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [Abstract] [Full Text] [Related]

  • 6. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E, Minelli R, Gardini E, Bianconi L, Salvi M, Gavaruzzi G, Ugolotti G, Braverman LE.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [Abstract] [Full Text] [Related]

  • 7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 8. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
    Lazarus JH, Marchant B, Alexander WD, Clark DH.
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
    [Abstract] [Full Text] [Related]

  • 9. Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.
    Taurog A, Dorris ML.
    Endocrinology; 1988 Feb; 122(2):592-601. PubMed ID: 3338414
    [Abstract] [Full Text] [Related]

  • 10. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
    Paschke R, Vogg M, Kristoferitsch R, Aktuna D, Wawschinek O, Eber O, Usadel KH.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.
    Klatka M, Kaszubowska L, Grywalska E, Wasiak M, Szewczyk L, Foerster J, Cyman M, Rolinski J.
    Folia Histochem Cytobiol; 2014 Aug; 52(1):69-77. PubMed ID: 24802963
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease.
    Signore A, Pozzilli P, Di Mario U, Sensi M, Beales P, Andreani D.
    Clin Exp Immunol; 1985 Apr; 60(1):111-6. PubMed ID: 3159521
    [Abstract] [Full Text] [Related]

  • 13. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat.
    Rennie DP, McGregor AM, Keast D, Weetman AP, Foord SM, Dieguez C, Williams ED, Hall R.
    Endocrinology; 1983 Jan; 112(1):326-30. PubMed ID: 6847827
    [Abstract] [Full Text] [Related]

  • 14. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [Abstract] [Full Text] [Related]

  • 16. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A.
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 18. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B, Merrill SJ, Di Bari F, Antonelli A, Benvenga S.
    Theor Biol Med Model; 2018 Jan 09; 15(1):1. PubMed ID: 29310665
    [Abstract] [Full Text] [Related]

  • 19. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E.
    Thyroid; 2006 Mar 09; 16(3):295-302. PubMed ID: 16571093
    [Abstract] [Full Text] [Related]

  • 20. The effect of methimazole on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat.
    Allen EM, Rajatanavin R, Nogimori T, Cushing G, Ingbar SH, Braverman LE.
    Am J Med Sci; 1986 Nov 09; 292(5):267-71. PubMed ID: 3777011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.